Li Y, Tam W, Yu Y, Zhuo Z, Xue Z, Tsang C
Biomark Res. 2023; 11(1):70.
PMID: 37468977
PMC: 10354955.
DOI: 10.1186/s40364-023-00510-8.
Kolovskaya O, Zyuzyukina A, Dassie J, Zamay G, Zamay T, Boyakova N
Front Mol Biosci. 2023; 10:1184285.
PMID: 37363395
PMC: 10285395.
DOI: 10.3389/fmolb.2023.1184285.
Song P, Fan C
Nat Chem. 2023; 15(6):747-748.
PMID: 37248343
DOI: 10.1038/s41557-023-01215-z.
Kichkailo A, Narodov A, Komarova M, Zamay T, Zamay G, Kolovskaya O
Mol Ther Nucleic Acids. 2023; 32:267-288.
PMID: 37090419
PMC: 10119962.
DOI: 10.1016/j.omtn.2023.03.015.
Poolsup S, Zaripov E, Huttmann N, Minic Z, Artyushenko P, Shchugoreva I
Mol Ther Nucleic Acids. 2023; 31:731-743.
PMID: 36816615
PMC: 9927813.
DOI: 10.1016/j.omtn.2023.02.010.
Aptamers as Theragnostic Tools in Prostate Cancer.
Cruz-Hernandez C, Rodriguez-Martinez G, Cortes-Ramirez S, Morales-Pacheco M, Cruz-Burgos M, Losada-Garcia A
Biomolecules. 2022; 12(8).
PMID: 36008950
PMC: 9406110.
DOI: 10.3390/biom12081056.
Ultrasensitive fluorescent aptasensor for MUC1 detection based on deoxyribonuclease I-aided target recycling signal amplification.
Zhang J, Ran F, Zhou W, Shang B, Yu F, Wu L
RSC Adv. 2022; 8(56):32009-32015.
PMID: 35547495
PMC: 9085725.
DOI: 10.1039/c8ra06498a.
Aptamer Targets Triple-Negative Breast Cancer through Specific Binding to Surface CD49c.
Wan Q, Zeng Z, Qi J, Zhao Y, Liu X, Chen Z
Cancers (Basel). 2022; 14(6).
PMID: 35326720
PMC: 8946172.
DOI: 10.3390/cancers14061570.
Stable DNA Aptamer-Metal-Organic Framework as Horseradish Peroxidase Mimic for Ultra-Sensitive Detection of Carcinoembryonic Antigen in Serum.
Sha L, Zhu M, Lin F, Yu X, Dong L, Wu L
Gels. 2021; 7(4).
PMID: 34842664
PMC: 8628696.
DOI: 10.3390/gels7040181.
Selection of DNA Aptamers for Differentiation of Human Adipose-Derived Mesenchymal Stem Cells from Fibroblasts.
Melo M, Cunha P, de Miranda M, Barbosa J, Faria J, Rodrigues M
Appl Biochem Biotechnol. 2021; 193(11):3704-3718.
PMID: 34363139
DOI: 10.1007/s12010-021-03618-5.
Advances in Aptamer-Based Biomarker Discovery.
Huang J, Chen X, Fu X, Li Z, Huang Y, Liang C
Front Cell Dev Biol. 2021; 9:659760.
PMID: 33796540
PMC: 8007916.
DOI: 10.3389/fcell.2021.659760.
Aptamers used for biosensors and targeted therapy.
Ning Y, Hu J, Lu F
Biomed Pharmacother. 2020; 132:110902.
PMID: 33096353
PMC: 7574901.
DOI: 10.1016/j.biopha.2020.110902.
High-efficiency enrichment enables identification of aptamers to circulating Plasmodium falciparum-infected erythrocytes.
Oteng E, Gu W, McKeague M
Sci Rep. 2020; 10(1):9706.
PMID: 32546848
PMC: 7298056.
DOI: 10.1038/s41598-020-66537-1.
Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells.
Affinito A, Quintavalle C, Esposito C, Roscigno G, Giordano C, Nuzzo S
Mol Ther Nucleic Acids. 2020; 20:176-185.
PMID: 32169805
PMC: 7068199.
DOI: 10.1016/j.omtn.2020.02.005.
A DNA aptamer for binding and inhibition of DNA methyltransferase 1.
Wang L, Lee J, Gao L, Yin J, Duan Y, Jimenez L
Nucleic Acids Res. 2019; 47(22):11527-11537.
PMID: 31733056
PMC: 7145629.
DOI: 10.1093/nar/gkz1083.
Elucidation and Structural Modeling of CD71 as a Molecular Target for Cell-Specific Aptamer Binding.
Wu X, Liu H, Han D, Peng B, Zhang H, Zhang L
J Am Chem Soc. 2019; 141(27):10760-10769.
PMID: 31185171
PMC: 6625514.
DOI: 10.1021/jacs.9b03720.
Updates on Aptamer Research.
Ali M, Elsherbiny M, Emara M
Int J Mol Sci. 2019; 20(10).
PMID: 31117311
PMC: 6566374.
DOI: 10.3390/ijms20102511.
Aptamer-based targeted therapy.
Zhu G, Chen X
Adv Drug Deliv Rev. 2018; 134:65-78.
PMID: 30125604
PMC: 6239901.
DOI: 10.1016/j.addr.2018.08.005.
Time-lapse imaging of molecular evolution by high-throughput sequencing.
Nguyen Quang N, Bouvier C, Henriques A, Lelandais B, Duconge F
Nucleic Acids Res. 2018; 46(15):7480-7494.
PMID: 29982617
PMC: 6125620.
DOI: 10.1093/nar/gky583.
[Study on the application of aptamers in the screening of tumor serum markers].
Ma S, Zeng J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2018; 35(2):320-323.
PMID: 29745541
PMC: 9935087.
DOI: 10.7507/1001-5515.201710026.